The Influence of Cobicistat or Ritonavir on Dabigatran Pharmacokinetics and Pharmacodynamics in Healthy Volunteers
Latest Information Update: 29 Sep 2017
At a glance
- Drugs Dabigatran etexilate (Primary) ; Cobicistat; Ritonavir
- Indications HIV infections; Thromboembolism
- Focus Pharmacokinetics
- 01 Sep 2017 Results assessing the influence of abcb1 single nucleotide polymorphisms on dabigatran exposure alone and in combination with ritonavir and cobicistat, published in the Clinical Pharmacology in Drug Development Conference: 2017 Annual Meeting of the American College of Clinical Pharmacology, ACCP 2017.
- 28 Aug 2017 Results published in the Antimicrobial Agents and Chemotherapy
- 16 Feb 2017 Results presented at the 24th Conference on Retroviruses and Opportunistic Infections.